In this frame it is noteworthy that the recovery of the cellular protein TRIM8 reactivates the p53 pathway upon drugs treatment in RCC cell line, because it prevents MDM2 binding to p53, as we have here shown. This evidence concerns the gene MDM2 and renal cell carcinoma.